단백질 발현 시장 : 산업 동향 및 세계 예측(-2035년) - 단백질 발현 시스템 유형별, 단백질 발현 관련 제품별, 응용 분야별, 최종 사용자별, 운영 유형별, 지역별, 주요 기업별
Protein Expression Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Type of Protein Expression System, Protein Expression-related Offerings, Application Area, End-users, Type of Operation, Geography and Key Players
상품코드:1549404
리서치사:Roots Analysis
발행일:2024년 07월
페이지 정보:영문 165 Pages
라이선스 & 가격 (부가세 별도)
한글목차
단백질 발현 시장 규모는 2024년 27억 달러에 달할 것으로 예상되며, 예측 기간인 2024-2035년 동안 8%의 연평균 복합 성장률(CAGR)을 나타낼 것으로 예상됩니다.
긴 아미노산 사슬로 구성된 단백질은 신약, 치료 및 진단 도구 개발에서 점점 더 중요해지고 있습니다. 다용도성, 대사 안정성, 표적 특이성, 높은 친화력으로 인해 단백질은 치료제로서 매력적인 후보로 떠오르고 있습니다. 실제로 2023년 매출 상위 의약품의 50%는 단백질 기반 치료제가 될 것으로 예상되며, 암, 면역질환, 감염성 질환, 당뇨병 등 다양한 만성질환 치료제로 미국 FDA의 승인을 받은 20개 이상의 단백질 기반 치료제가 있습니다. 또한, 2023년 이후 단백질 발현과 관련된 6,500건 이상의 특허가 부여되었습니다.
단백질 치료제에 대한 수요 증가와 혁신적인 생산 방법의 필요성으로 인해 제약회사들은 재조합 단백질 생산에 단백질 발현 시스템을 채택하고 있습니다. 이러한 시스템은 광범위한 표적 분자를 생산할 수 있고, 높은 수율, 짧은 개발 기간, 낮은 생산 비용 등 여러 가지 이점을 제공합니다. 또한, 업체들은 단백질 발현을 위한 키트 및 시약을 개발하여 독성 단백질, 막 단백질, 번역 후 변형 단백질을 포함한 복잡한 단백질의 합성을 가능하게 하고 있습니다.
만성질환의 발병률이 지속적으로 증가함에 따라 단백질 치료제에 대한 수요가 증가할 것으로 예상됩니다. 단백질 기반 리드 화합물의 임상시험 및 상용화에 대한 성숙과 발현 시스템의 발전은 예측 기간 동안 단백질 발현 시장의 성장을 가속할 것으로 예상됩니다.
이 보고서는 세계 단백질 발현 시장을 조사했으며, 시장 개요와 함께 단백질 발현 시스템 유형별/단백질 발현 관련 제공 제품별/응용 분야별/최종 사용자별/운영 유형별/지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다. 제공합니다.
목차
제1장 서문
제2장 조사 방법
제3장 경제 및 기타 프로젝트 특유의 고려사항
제4장 주요 요약
제5장 서론
제6장 시장 구도 : 주요 단백질 발현 프로바이더
주요 단백질 발현 프로바이더 : 전체적인 시장 구도
제7장 기업 경쟁력 분석 : 주요 단백질 발현 프로바이더
주요 파라미터와 조사 방법
기업 경쟁력 분석 : 단백질 발현 프로바이더 :
단백질 발현 프로바이더 : 주요 시장 진출기업 벤치마킹 분석
제8장 기업 개요
Agilent Technologies
Ajinomoto Bio-Pharma Services
Charles River Laboratories
GenScript Biotech
Lonza
Merck
QIAGEN
Sartorius
Thermo Fisher Scientific
WuXi Biologics
기타
제9장 밸류체인 분석
제10장 시장에 대한 영향 분석 : 촉진요인, 억제요인, 기회, 과제
제11장 세계의 단백질 발현 시장
제12장 단백질 발현 시장, 단백질 발현 시스템 유형별
제13장 단백질 발현 시장, 단백질 발현 관련 제공 제품별
제14장 단백질 발현 시장, 응용 분야별
제15장 단백질 발현 시장, 최종사용자별
제16장 단백질 발현 시장, 운영 유형별
제17장 단백질 발현 시장, 지역별
제18장 단백질 발현 시장, 주요 기업별
제19장 주요 인사이트
제20장 부록 1 : 표 형식 데이터
제21장 부록 2 : 기업·단체 리스트
LSH
영문 목차
영문목차
The Protein Expression Market is valued at USD 2.7 billion in 2024 growing at a CAGR of 8% during the forecast period 2024-2035.
Proteins, composed of long chains of amino acids, have become increasingly important in the development of new drugs, treatments, and diagnostic tools. Their versatility, metabolic stability, target specificity, and high affinity have made them attractive candidates for therapeutic applications. In fact, 50% of the top-selling drugs in 2023 are protein-based therapeutics, with over 20 such treatments approved by the US FDA for the treatment of various chronic diseases, including cancers, immune disorders, infections, and diabetes. Furthermore, since 2023, over 6,500 patents related to protein expression have been granted.
The growing demand for protein therapeutics and the need for innovative production methods have driven pharmaceutical companies to adopt protein expression systems for the production of recombinant proteins. These systems offer several advantages, including the ability to produce a wide range of target molecules, higher yields, shorter development times, and lower production costs. Additionally, companies have developed kits and reagents for protein expression, enabling the synthesis of complex proteins, including toxic proteins, membrane proteins, and post-translationally modified proteins.
As the incidence of chronic diseases continues to rise, the demand for protein therapeutics is likely to increase. The maturation of protein-based leads into clinical trials and commercialization, as well as advancements in expression systems, are expected to drive the growth of the protein expression market over the forecast period.
Key Market Segments
Type of Protein Expression System
Algal Expression Systems
Cell-free Expression Systems
Insect Expression Systems
Mammalian Expression Systems
Prokaryotic Expression Systems
Yeast Expression Systems
Protein Expression-related Offerings
Competent Cells
Expression Vectors
Instruments
Kits and Reagents
Protein Expression Services
Application Area
Research and Diagnostics
Therapeutics
End Users
Academic and Research Institutes
CROs and CDMOs
Pharmaceutical and Biotechnology Companies
Other End-users
Type of Operation
In-house Operations
Outsourced Operations
Geography
North America (US and Canada)
Europe (France, Germany, Italy, Spain, UK and Rest of Europe)
Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific)
Latin America
Middle East and North Africa
Research Coverage:
This report provides a comprehensive introduction to protein expression, including its process and various applications. It explores different types of expression systems, their key features, and uses. Additionally, it discusses challenges and recent trends in protein expression, providing insights for researchers and industry professionals.
A comprehensive assessment of protein expression product and service providers, along with information on several relevant parameters, such as year of establishment, company size (in terms of employee count) and location of headquarters (region and country), type of protein expression systems (algal, cell-free, insect, mammalian, prokaryotic and yeast expression systems), protein expression-related offerings (competent cells, expression vectors, instruments, kits and reagents and protein expression services) and application areas (industrial, research and therapeutic).
This report provides a comprehensive competitiveness analysis of protein expression product and service providers. Key parameters considered include developer strength (company size and experience) and portfolio strength (type of protein expression systems, offerings, and application areas). The report also conducts a benchmarking analysis, highlighting the focus areas of companies and comparing their capabilities among competitors. This analysis provides valuable insights into the strengths and weaknesses of leading protein expression providers, enabling informed decision-making.
This report provides in-depth profiles of key companies in the protein expression market. Each profile includes a brief overview, protein expression offerings, financial information, recent developments, and a future outlook. This comprehensive analysis helps readers understand the market dynamics, company strengths, and growth prospects.
This report provides an in-depth analysis of the protein expression value chain, including supplier-end user relationships and process stages from design to large-scale production.
This report examines the protein expression market's growth drivers, restraints, emerging opportunities, and existing challenges, providing a comprehensive analysis of the factors influencing the market's trajectory.
This report provides a detailed estimate of the current market size and future growth potential of the protein expression market from 2024 to 2035. Our analysis is based on adoption trends, secondary and primary research, and reliable data. We have also provided a breakdown of the current and forecasted opportunity within the protein expression industry. To account for future uncertainties, we have developed three forecast scenarios: conservative, base, and optimistic, representing different market growth tracks. These scenarios provide a robust outlook for the market, allowing stakeholders to plan and prepare for various possibilities.
Comprehensive prediction of the current and future opportunity within protein expression market across different types of protein expression systems, such as algal, cell-free, insect, mammalian, prokaryotic and yeast expression systems.
Detailed predictions of the current and future opportunity within protein expression domain across various protein expression-related offerings, such as competent cells, expression vectors, instruments, kits and reagents and protein expression services.
Comprehensive assessment of the current and future opportunity within protein expression industry across various application areas, such as research and diagnostics, and therapeutics.
Comprehensive projections of the current and future opportunity within protein expression market across different end-users, such as academic and research institutes, CROs and CDMOs, pharmaceutical and biotechnology companies and other end-users.
Comprehensive prediction of the current and future opportunity within the market for protein expression across different types of operation, such as in-house operations and outsourced operations.
Comprehensive projections of the current and future opportunity within protein expression market across various geographies, such as North America (US and Canada), Europe (France, Germany, Italy, Spain, UK and Rest of Europe), Asia-Pacific (India, China, Japan, South Korea and Rest of Asia-Pacific), Latin America and Middle East and North Africa.
In-depth discussion on the leading protein expression product and service providers in this industry, highlighting their protein expression portfolio and annual revenues of business segment that includes protein expression.
Key Benefits of Buying this Report
The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Protein Expression Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
Agilent Technologies
Ajinomoto Bio-Pharma Services
Aldevron
Cayman Chemical
Charles River Laboratories
Domainex
Eurofins CALIXAR
GeNext Genomics
GenScript Biotech
Lonza
Merck KGaA
New England Biolabs
ProMab
Promega
ProteoGenix
QIAGEN
Sartorius
Synbio Technologies
Syngene
Takara Bio
Thermo Fisher Scientific
WuXi Biologics
TABLE OF CONTENTS
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation
3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage and Foreign Exchange Rate
3.2.2.1. Major Currencies Affecting the Market
3.2.2.2. Factors affecting Currency Fluctuations and Foreign Exchange Rates
3.2.2.3. Impact of Foreign Exchange Rate Volatility on Market
3.2.2.4. Strategies For Mitigating Foreign Exchange Risk
3.2.3. Trade Policies
3.2.3.1. Impact of Trade Barriers on the Market
3.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers
3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution
4. EXECUTIVE SUMMARY
5. INTRODUCTION
5.1. An Overview of Protein Expression
5.2. Schematic Representation of Protein Expression Process
5.3. Applications of Protein Expression
5.4. Types of Protein Expression Systems
5.5. Challenges in Protein Expression
5.6. Recent Trends
6. MARKET LANDSCAPE: KEY PROTEIN EXPRESSION PROVIDERS
6.1. Key Protein Expression Providers: Overall Market Landscape
6.1.1. Analysis by Year of Establishment
6.1.2. Analysis by Company Size
6.1.3. Analysis by Location of Headquarters (Region)
6.1.4. Analysis by Location of Headquarters (Country)
6.1.5. Analysis by Type of Protein Expression System
6.1.6. Analysis by Protein Expression-related Offerings
6.1.7. Analysis by Application Area
7. COMPANY COMPETITIVENESS ANALYSIS: KEY PROTEIN EXPRESSION PROVIDERS
7.1. Key Parameters and Methodology
7.2. Company Competitiveness Analysis: Protein Expression Providers:
7.3. Protein Expression Providers: Benchmarking Analysis of Key Players
7.3.1. Spider Web Analysis: Benchmarking of Key Players
7.3.1.1. Agilent Technologies
7.3.1.2. Ajinomoto Bio-Pharma Services
7.3.1.3. Charles River Laboratories
7.3.1.4. GenScript Biotech
7.3.1.5. Lonza
7.3.1.6. Merck
7.3.1.7. QIAGEN
7.3.1.8. Sartorius
7.3.1.9. Thermo Fisher Scientific
7.3.1.10. WuXi Biologics
7.3.2. Protein Expression Providers: Parameter-wise Benchmarking
7.3.2.1. By Years of Experience
7.3.2.2. By Company Size
7.3.2.3. By Annual Revenues
7.3.2.4. By Type of Protein Expression System
7.3.2.5. By Number of Protein Expression-related Offerings
7.3.2.6. By Number of Application Areas
8. COMPANY PROFILES
8.1. Agilent Technologies
8.1.1. Company Details
8.1.2. Protein Expression-related Offerings
8.1.3. Financial Details
8.1.4. Recent Developments and Future Outlook
8.2. Ajinomoto Bio-Pharma Services
8.2.1. Company Details
8.2.2. Protein Expression-related Offerings
8.2.3. Financial Details
8.2.4. Recent Developments and Future Outlook
8.3. Charles River Laboratories
8.3.1. Company Details
8.3.2. Protein Expression-related Offerings
8.3.3. Financial Details
8.3.4. Recent Developments and Future Outlook
8.4. GenScript Biotech
8.4.1. Company Details
8.4.2. Protein Expression-related Offerings
8.4.3. Financial Details
8.4.4. Recent Developments and Future Outlook
8.5. Lonza
8.5.1. Company Details
8.5.2. Protein Expression-related Offerings
8.5.3. Financial Details
8.5.4. Recent Developments and Future Outlook
8.6. Merck
8.6.1. Company Details
8.6.2. Protein Expression-related Offerings
8.6.3. Financial Details
8.6.4. Recent Developments and Future Outlook
8.7. QIAGEN
8.7.1. Company Details
8.7.2. Protein Expression-related Offerings
8.7.3. Financial Details
8.7.4. Recent Developments and Future Outlook
8.8. Sartorius
8.8.1. Company Details
8.8.2. Protein Expression-related Offerings
8.8.3. Financial Details
8.8.4. Recent Developments and Future Outlook
8.9. Thermo Fisher Scientific
8.9.1. Company Details
8.9.2. Protein Expression-related Offerings
8.9.3. Financial Details
8.9.4. Recent Developments and Future Outlook
8.10. WuXi Biologics
8.10.1. Company Details
8.10.2. Protein Expression-related Offerings
8.10.3. Financial Details
8.10.4. Recent Developments and Future Outlook
8.11. Other Prominent Players
8.11.1. Aldevron
8.11.1.1. Company Details
8.11.1.2. Protein Expression-related Offerings
8.11.2. Cayman Chemical
8.11.2.1. Company Details
8.11.2.2. Protein Expression-related Offerings
8.11.3. Domainex
8.11.3.1. Company Details
8.11.3.2. Protein Expression-related Offerings
8.11.4. Eurofins CALIXAR
8.11.4.1. Company Details
8.11.4.2. Protein Expression-related Offerings
8.11.5. GeNext Genomics
8.11.5.1. Company Details
8.11.5.2. Protein Expression-related Offerings
8.11.6. New England Biolabs
8.11.6.1. Company Details
8.11.6.2. Protein Expression-related Offerings
8.11.7. ProMab Biotechnologies
8.11.7.1. Company Details
8.11.7.2. Protein Expression-related Offerings
8.11.8. Promega
8.11.8.1. Company Details
8.11.8.2. Protein Expression-related Offerings
8.11.9. ProteoGenix
8.11.9.1. Company Details
8.11.9.2. Protein Expression-related Offerings
8.11.10. Synbio Technologies
8.11.10.1. Company Details
8.11.10.2. Protein Expression-related Offerings
8.11.11. Syngene
8.11.11.1. Company Details
8.11.11.2. Protein Expression-related Offerings
8.11.12. Takara Bio
8.11.12.1. Company Details
8.11.12.2. Protein Expression-related Offerings
9. VALUE CHAIN ANALYSIS
9.1. Brief Overview on Protein Expression Process and Stakeholders Involved
9.2. Schematic Representation of Protein Expression from Design to Large Scale Production
10. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
10.1. Market Drivers
10.2. Market Restraints
10.3. Market Opportunities
10.4. Market Challenges
11. GLOBAL PROTEIN EXPRESSION MARKET
11.1. Key Assumptions and Methodology
11.2. Global Protein Expression Market, Historical Trends (2020-2023) and Forecasted Estimates (2024-2035)
11.2.1. Scenario Analysis
11.2.1.1. Conservative Scenario
11.2.1.2. Optimistic Scenario
12. PROTEIN EXPRESSION MARKET, BY TYPE OF PROTEIN EXPRESSION SYSTEM
12.1. Key Assumptions and Methodology
12.2. Protein Expression Market: Distribution by Type of Protein Expression System, 2020, 2024 and 2035
